Inlyta is a prescription medication used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC) when one prior drug treatment for this disease has not worked. Inlyta belongs to a group of drugs called tyrosine kinase inhibitors, which work by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
This medication comes in tablet form and is taken twice daily, with or without food. Inlyta tablets must be swallowed whole with a glass of water.
Common side effects of Inlyta include diarrhea, tiredness, and nausea.
Citation:
"Inlyta", DailyMed: Current Medication Information; U.S. National Library of Medicine. [4]
Axitinib [6]
Contributor:
Anyssa Garza, PharmD [3] Teresa Brucker, Pharm.D [10] Eric Ho, Pharm.D [11] Beth Bolt, RPh [12] Photo:
published_note:
RX Label Type:
Long Title:
Inlyta treats cancer of the kidneys. Inlyta can cause diarrhea and increased blood pressure. Blood pressure should be monitored regularly during treatment. Black Box Warning Image:
Side Effects Image:
Inform MD Image:
